Home › Funds › DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. › CRL

DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. position in CRL

CHARLES RIV LABS INTL INC · Health Care

DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. reported holding 12,150 shares of CRL (CHARLES RIV LABS INTL INC) in its Q3 2026 13F filing — a position valued at US$3.6M, representing 0.21% of its reported portfolio and ranking #50 among its reported holdings. DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. first reported this position in Q3 2026.

Latest position (Q3 2026)12.15K sh
Reported value held$3.58M
Portfolio Weight0.21%
First reportedQ3 2026
Last changeNew
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD.'s CRL position evolved

DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. first disclosed a stake in CRL in Q3 2026 at 12,150 shares (US$3.6M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 12.15K $3.58M New

About CRL and 13F data

CRL (CHARLES RIV LABS INTL INC) is a Health Care company. 29 other funds we track also report a position in CRL — the largest reported positions include ARIEL INVESTMENTS, LLC (US$352.0M), EARNEST PARTNERS LLC (US$320.7M), Allspring Global Investments Holdings, LLC (US$254.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRL

All CRL fund holders →

FAQ

How long has DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. held CRL?

DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. has disclosed CRL holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD.'s current position in CRL?

As of Q3 2026, DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. holds 12.15K shares of CRL (CHARLES RIV LABS INTL INC), valued at $3.58M, representing 0.21% of its reported portfolio and ranking #50.

Has DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. been buying or selling CRL?

In the latest 13F filing (Q3 2026), DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. newly opened its position in CRL.

Which other funds hold CRL?

Other major institutional holders of CRL include ARIEL INVESTMENTS, LLC, EARNEST PARTNERS LLC, Allspring Global Investments Holdings, LLC, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.